GADD45a-GFP GreenScreen HC genetoxicity screening assay

Expert Opinion on Drug Metabolism and Toxicology

Volumn 4, Issue 6, 2008, Pages 827-835

  Walmsley, Richard M ^a  

^a Gentronix Ltd   (United Kingdom)

Author keywords

Aneugens; Carcinogenicity; Clastogens; Genotoxicity; Hazard; Mutagens; Safety; Screening

Indexed keywords

CARCINOGEN; CIS ACTING ELEMENT; GREEN FLUORESCENT PROTEIN; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45; MUTAGENIC AGENT;

ARTICLE; CARCINOGENICITY; CHEMICAL CARCINOGENESIS; CHROMOSOME ABERRATION; FALSE POSITIVE RESULT; GENETIC SCREENING; GENOTOXICITY; HUMAN; IN VITRO STUDY; LYMPHOMA; MAMMAL; MICRONUCLEUS TEST; MUTAGENICITY; NONHUMAN; PEER REVIEW; PRACTICE GUIDELINE; PREDICTION; RELIABILITY; SPECTROPHOTOMETRY; TOXICITY TESTING;

CELL CYCLE PROTEINS; GENES, REPORTER; GREEN FLUORESCENT PROTEINS; HUMANS; MUTAGENICITY TESTS; MUTAGENS; NUCLEAR PROTEINS; RECOMBINANT FUSION PROTEINS; REGULATORY ELEMENTS, TRANSCRIPTIONAL; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; TRANSCRIPTION, GENETIC;

MAMMALIA;

EID: 48949117153     PISSN: 17425255     EISSN: None     Source Type: Journal    
DOI: 10.1517/17425255.4.6.827     Document Type: Article

References (31)

1. Ames B, McCann J, Yamasuki E. Methods for detecting carcinogens and mutagens with the Salmonella/mammalian microsome mutagenicity test. Mutat Res 1975;31:347-64
2. Feinberg AP. Cancer epigenetics takes center stage. Proc Natl Acad Sci USA 2001;98:392-4
3. Snyder RD, Green JW. A review of the genotoxicity of marketed pharmaceuticals. Mutat Res 2001;88:151-69
4. Physicians' Desk Reference, 55th edition. Montvale, NJ: Medical Economics Co. Inc.; 2001
5. Kirkland D, Aardema M, Henderson L, Muller L. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens I. Sensitivity, specificity and relative predictivity. Mutat Res 2005;584:1-256
6. Kirkland D, Aardema M, Müller L, Hayashi M. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens II. Further analysis of mammalian cell results, relative predictivity and tumour profiles. Mutat Res 2006;608:29-42
7. Matthews EJ, Kruhlak NL, Cimino MC, et al. An analysis of genetic toxicity, reproductive and developmental toxicity, and carcinogenicity data. I. Identification of carcinogens using surrogate endpoints. Regul Toxicol Pharmacol 2006;44:83-96
8. US Federal Register. International Conference on Harmonisation: draft guidance on S2(R1) genotoxicity testing and data interpretation for pharmaceuticals intended for human use; availability. Available on: http://www.fda.gov/OHRMS/DOCKETS/98fr/08-1076.pdf 2008;73(59):16024-25
9. Kirkland D, Pfuhler S, Tweats D, et al. How to reduce false positive results when undertaking in vitro genotoxicity testing and thus avoid unnecessary follow-up animal tests: report of an ECVAM Workshop. Mutat Res 2007;628:31-55
10. Thybaud V, Aardema M, Casciano D, et al. Relevance and follow-up of positive results in in vitro genetic toxicity assays: an ILSI-HESI initiative. Mutat Res 2007:633:67-79
11. Hastwell PW, Chai L, Roberts KJ, et al. High-specificity and high-sensitivity genotoxicity assessment in a human cell line: validation of the GreenScreen HC GADD45a-GFP genotoxicity assay. Mutat Res 2006;607:160-75
12. Newton R, Aardema M, Aubrecht J. The utility of DNA microarrays for characterizing genotoxicity. Environ Health Perspect 2004;112:420-2
13. Jacobson-Kram D, Contrera J. Genetic toxicity assessment: employing the best science for human safety evaluation. Part I. Early screening for potential human mutagens. Toxicol Sci 2007;96:16-20
14. Fornace AJ Jr, Jackman J, Hollander MC, et al. Genotoxic-stress-response genes and growth-arrest genes: Gadd, MyD and other genes induced by treatment eliciting growth arrest. Ann NY Acad Sci 1992;663:139-53
15. Hollander MC, Alamo I, Jackman J, et al. Analysis of the mammalian Gadd45 gene and its response to DNA damage. J Biol Chem 1993;268:24385-93
16. Nachman MW, Crowell SL. Estimate of the mutation rate per nucleotide in humans. Genetics 2000;156:297-304
17. Knight AW, Goddard NJ, Billinton N, et al. Fluorescence polarization discriminates green fluorescent protein from interfering autofluorescence in a microplate assay for genotoxicity. J Biochem Biophys Methods 2002;51:165-77
18. Knight AW, Billinton N, Cahill PA, et al. An analysis of results from 305 compounds tested with the yeast RAD54-GFP genotoxicity assay (GreenScreen GC), including relative predictivity of regulatory tests and rodent carcinogenesis and performance with autofluorescent and coloured compounds. Mutagenesis 2007;22:409-16
19. Hartung T, Bremer S, Casati S, et al. A modular approach to the ECVAM principles on test validity. Altern Lab Anim 2004;32:467-72
20. Billinton N, Hastwell PW, Beerens D, et al. Interlaboratory assessment of the GreenScreen HC GADD45a-GFP genotoxicity screening assay: an enabling study for independent validation as an alternative method. Mutat Res Genet Toxicol Environ Mutagen 2008; In press. Epub doi:10.1016/ j.mrgentox.2008.02.011
21. Gold LS. The carcinogenic potency project. 2007. Available from: htrp:// potency.berkeley.edu/cpdb.html
22. Gold LS, Slone TH, Manley NB, Ames BN. Misconceptions about the causes of cancer. Risk Controversy Series 3. Vancouver, BC: The Fraser Institute, Centre for Studies in Risk, Regulation and Environment; 2002
23. Gold LS, David W, Gaylor DW, Slone TH. Comparison of cancer risk estimates based on a variety of risk assessment methodologies. Regul Toxicol Pharmacol 2003;37:45-53
24. Lave LB, Ennever FK, Rosenkranz HS, Omenn GS. Information value of the rodent bioassay. Nature 1988;336:631-3
25. Ashby J, Tinwell H. The rodent bone marrow micronucleus assay: contrast between its sensitiviy to human carcinogens and its sensitivity to NTP rodent carcinogens. Mutat Res 1996;352:181-4
26. Morita T, Asano N, Awogi T, et al. Evaluation of the rodent micronucleus assay in the screening of IARC carcinogens (Groups 1, 2A and 2B): the summary report of the 6th collaborative study by CSGMT/JEMS. Mutat Res389:3-122
27. Tweats DJ, Blakey D, Heflich RH, et al. Report of the IWGT working group on strategies and interpretation of regulatory in vivo tests. I. Increases in micronucleated bone marrow cells in rodents that do not indicate genotoxic hazards. Mutat Res 2007;627:78-91
28. Jagger C, Tate M, Cahill P, et al. Genotoxicity assessment using a GADD45a-GFP reporter assay in a p53 competent human cell host: metabolic activation, flow cytometry and data update. Poster, Environmental Mutagen Society Annual Meeting; 2006
29. Ku WW, Bigger A, Brambilla G, et al. Strategy for genotoxicity testing: metabolic considerations. Mutat Res 2007;627:59-77
30. Flückiger-Isler S, Baumeister M, Braun K, et al. Assessment of the performance of the Ames II™ assay: a collaborative study with 19 coded compounds. Mutat Res 2004;558:181-97
31. Reifferscheid G, Heil J, Oda Y, Zahn RK. A microplate version of the SOS/ umu-test for rapid detection of genotoxins and genotoxic potentials of environmental samples. Mutat Res 1991;253:215-22